Abstract
In the United States, approximately half of patients with a positive sentinel lymph node biopsy undergo a completion lymphadenectomy. Because of the equivocal survival benefits in pursuing a completion lymphadenectomy in these patients, surgeons must weigh the postoperative morbidity of the operation with concerns facing a patient's quality of life and risk of tumor recurrence. We discuss the value of a completion lymphadenectomy in light of the uncertainties facing this management strategy for melanoma. J. Surg. Oncol. 2016;114:281–287.
Original language | English (US) |
---|---|
Pages (from-to) | 281-287 |
Number of pages | 7 |
Journal | Journal of surgical oncology |
Volume | 114 |
Issue number | 3 |
DOIs | |
State | Published - Sep 1 2016 |
Keywords
- lymphadenectomy
- melanoma
- sentinel lymph node
- value
ASJC Scopus subject areas
- Surgery
- Oncology